TNYA logo

Tenaya Therapeutics, Inc.

TNYA
Healthcare|Biotechnology|US
$0.36
+0.04 (+13.99%)
DCF Value
$0.57
Tangible Book / Share
$0.24
Cash / Share
$0.30
Next Earnings Report
Mar 10, 2027
EPS est. -$0.09 · Revenue est. $2.5M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Dec 12, 2025 (424B5). Possible dilution.

Upcoming Data Readouts (3)

Aug 2027
Est. completion
P1P2Hypertrophic Cardiomyopathy
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
NCT05836259n=30
Jun 2028
Est. completion
Cardiomyopathy
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
NCT05112237n=200
Mar 2030
Est. completion
Arrhythmogenic Right Ventricular Cardiomyopathy
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
NCT06311708n=200

Recent Press Releases

Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 4, 2026 · GlobeNewsWire
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
Sep 14, 2026 · GlobeNewsWire
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
Sep 3, 2026 · GlobeNewsWire

SEC Filings (70)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 202610-QQuarterly reportDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Oct 23, 2026DEFA14AProxy / shareholder voteDocumentIndex
Oct 23, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 13, 2026PRE 14AProxy / shareholder voteDocumentIndex
Aug 24, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 5, 2026S-8Employee stock planDocumentIndex
Aug 5, 202610-QQuarterly reportDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Jul 2, 20268-KMaterial eventDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
May 29, 20268-KMaterial eventDocumentIndex
May 6, 202610-QQuarterly reportDocumentIndex
May 6, 20268-KMaterial eventDocumentIndex
Apr 16, 2026ARSAnnual report to holdersDocumentIndex
Apr 16, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 16, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 11, 202610-KAnnual reportDocumentIndex
Mar 11, 20268-KMaterial eventDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Feb 26, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 12, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 3, 2026S-8Employee stock planDocumentIndex
Jan 30, 20268-KMaterial eventDocumentIndex
Jan 2, 20268-KMaterial eventDocumentIndex
Dec 17, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Dec 12, 20258-KMaterial eventDocumentIndex
Dec 12, 2025424B5Offering prospectusDocumentIndex
Dec 11, 2025424B5Offering prospectusDocumentIndex
Dec 11, 20258-KMaterial eventDocumentIndex
Nov 10, 202510-QQuarterly reportDocumentIndex
Nov 10, 20258-KMaterial eventDocumentIndex
Nov 7, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 6, 202510-QQuarterly reportDocumentIndex
Aug 6, 20258-KMaterial eventDocumentIndex
Jul 31, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jul 16, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 30, 20258-KMaterial eventDocumentIndex
May 15, 2025SC 13GPassive 5%+ stakeDocumentIndex